Mera-med.ru

Онкология
- Лечение онкологии
- Меланома
- Лейкоз
- Острый лейкоз
- Хронический лейкоз
- Лейкоз крови
- Рак



















практическая онкология

The private residence costs{stands} research ICON-3 in which 2039 patients Ic-IV with stages of a cancer яичников have taken part. In control group patients received карбоплатин in doze AUC> 5 or combination САР (500/50/50 mg / m2), in compared group - a combination цисплатина and паклитаксела (75/175 mg / m2). Treatment was carried out{was spent} each 3 weeks in volume of 6 rates. The preliminary data testify that time before progressing and general life expectancy was identical irrespective of used chemotherapy. Sick (57 %) in group карбоплатина and CAP received the majority таксаны as chemotherapy of the second line that explains rather good remote results. Подробнее...

The second purpose of operative treatment of the widespread cancer яичников is removal{distance} or the maximal resection as primariest tumour, and all its{her} metastasises. Removal{distance} of a great bulk of a tumour improves the general{common} condition of patients due to reduction of an intoxication and normalization of function of intestines. Besides циторедукция raises efficiency of the subsequent chemotherapy due to reduction of number of tumoral cells{cages} including resistant to chemotherapy, transition of the most part of the staying cells{cages} from a phase of rest in a phase of division, and removal{distance} it is bad васкуляризованных sites of a tumour in which hit of antineoplastic preparations is complicated. Подробнее...